Biologics Congress
Time:February 02-03, 2015
Venue:Scandic Berlin Potsdamer Platz Hotel, Berlin, DE
Organizer:LabRoots, Inc.
The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years. With growing commercial potential, good economic returns & lower attrition rates (when compared to small molecule drugs) and entry barriers on the manufacturing side reducing all the time, more and more companies are entering the expanding field.
The Biologics Congress has been designed to attract industry & academic experts working in all areas of protein and antibody research. This two day interactive meeting will help you further your own research, keep you abreast of your competitors and inform you about the latest technological advances in the area.
As well as an attractive discount, the benefits of (early) registration include:
-
Discover the very latest innovative research led by academics and industry
-
Hear from a 40-strong speaker faculty covering
-
Antibody-based therapeutics
-
Antibody-drug conjugates
-
Antibodies for cancer immunotherapy
-
Protein expression, purification & characterisation
-
Protein biotherapeutics
-
Deliver your own poster presentation
-
Meet with solution providers offering the latest technology and advances in the area
-
Take part in one-to-one meetings
-
Network with your peers at the drinks reception
|
Keynote Speakers |
 |
Ralf Schumacher, Site Head Large Molecule Research Penzberg & pRED Center Manager, Roche, Germany |
|
|
|
 |
Paul Parren, SVP and Scientific Director, Genmab, The Netherlands
The Mechanism of Complement Activation: From Science to the Hexabody Platform |
Pharma Sources Insight July 2025
